"Rapid Reference to Osteoporosis Disease" will provide the reader with authoritative and accessible information from a clinical expert in the field, to assist with treatment decisions. Each title in the new "Rapid Reference Series" provides standard core content (epidemiology - management/ therapy) combined with the additional information, such as FAQs and patient organisations, needed by the GP to provide effective patient care. They also include drugs listings, clinical trials, information on future developments and web site listings to keep the reader up to speed with new developments and to extend their knowledge of the disease area. With patients becoming better informed about the nature and management of their conditions, "Rapid Reference" is a timely new series that offers GPs easy access to the best information for patient care and management.
Indice testuale
1. Introduction 2. Definition and Epidemiology 3. Pathophysiology 3.1 Bone structure 3.2 The cells of bone 3.3 Bone matrix 3.4 Bone remodelling 3.5 Regulation of bone mass and bone loss 3.5.1 Genetics 3.5.2 Sex hormones 3.5.3 Diet 3.5.4 Exercise 3.5.5 Smoking 3.5.6 Alcohol 3.5.7 Other risk factors 3.6 Diseases and drugs 3.6.1 Chronic Inflammatory disease 3.6.2 Gastrointestinal Disease 3.6.3 Thyrotoxicosis 3.6.4 Primary Hyperparathyroidism 3.6.5 Hypogonadism 3.6.6 Corticosteroids 3.6.7 Other drugs 4. Investigation and Diagnosis 4.1 Clinical Assessment 4.2 Bone densitometry 4.3 Quantitative Ultrasound 4.4 Plain Radiographs 4.5 Other Imaging techniques 4.6 Bone turnover markers 4.7 Genetic markers 4.8 Routine Biochemistry and haematology 4.9 Bone biopsy 5. Prevention of Osteoporosis 5.1 When should preventative treatment be used? 5.1.1 Diet 5.1.2 Exercise 5.1.3 Smoking alcohol and other factors 5.1.4 Calcium and vitamin D 5.1.5 HRT 5.1.6 Raloxifene 5.1.7 Tibolone 5.1.8 Bisphosphonates (Etidronate, Alendronate, Risedronate) 5.1.9 Agents in development (Zoledronate, Ibandronate) 6. Treatment of established osteoporosis 6.1 When should treatment be given? 6.1.1 Calcium and vitamin D 6.1.2 Active vitamin D metabolites 6.1.3 Calcitonin 6.1.4 Fluoride 6.1.5 Raloxifene 6.1.6 Cyclic etidronate, 6.1.7 Alendronate, 6.1.8 Risedronate 6.1.9 Agents in development (PTH, Zoledronate, Ibandronate) 7. Corticosteroid induced osteoporosis 7.1 Pathogenesis 7.2 Investigation 7.3 Prevention and Treatment 8. Osteoporosis in men 8.1 Pathogenesis 8.2 Investigation 8.3 Treatment 9. Osteogenesis imperfecta 9.1 Pathogenesis 9.2 Investigation 9.3 Treatment 10. Rare causes of osteoporosis 11. Frequently Asked Questions 12. References Appendix 1 - Drug treatments and doses Appendix 2 - Useful addresses and websites Index
